Ralph Smalling - 01 Sep 2025 Form 4 Insider Report for GENELUX Corp (GNLX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Sep 2025, 16:15:31 UTC
Prior SEC filing
29 Aug 2025
Next SEC filing
26 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas Zindrick, J.D.Attorney-in-Fact

Key filing fact

Ralph Smalling filed Form 4 for GENELUX Corp (GNLX) on 03 Sep 2025.

Key facts

  • This page summarizes Ralph Smalling's Form 4 filing for GENELUX Corp (GNLX).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 03 Sep 2025, 16:15.

Change

  • Previous filing in this sequence was filed on 29 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001983288 Primary reporting owner

Smalling Ralph

Relationship
Head of Regulatory
Address
C/O GENELUX CORPORATION, 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Signature
/s/ Thomas Zindrick, J.D.Attorney-in-Fact
Signature date
03 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GNLX transaction

Common Stock

Award

Transaction value
$0
Shares
+10,000
Change %
+16%
Price
$0.000000
Shares after
70,990
Date
01 Sep 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GNLX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-8,333
Change %
-100%
Price
Shares after
0
Date
01 Sep 2025
Ownership
Direct
Underlying class
Common stock
Underlying amount
8,333
Exercise price
$6.00
Footnotes
F2, F3
GNLX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+8,333
Change %
Price
Shares after
8,333
Date
01 Sep 2025
Ownership
Direct
Underlying class
Common stock
Underlying amount
8,333
Exercise price
$3.33
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common Stock upon vesting. The RSUs will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 12 equal quarterly (every 3 months) installments thereafter.

Footnote F2

The shares subject to the option vest as follows: 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Footnote F3

The transactions reported herein reflect a one-time reduction of the exercise price of the stock option, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration date or the vesting schedule of the stock option.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .